About

ST-segment elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality. Challenges in diagnosis remain due to variability in ECG presentation, conditions with similar presentations, variability in the electrical manifestation of ST-segment elevation on ECG, and systems issues with access to rapid diagnosis that can make this diagnosis challenging.

Given the significant morbidity and mortality associated with STEMI, there has been a push to improve the timely diagnosis of STEMI to ensure patients receive therapy faster. However, there remain challenges in diagnosis.

Articles

Combined Intracoronary Glycoprotein Inhibitors and Manual Thrombus Extraction in Patients with Acute ST-segment Elevation Myocardial Infarction - Does Incorporation of Both Have a Legitimate Role?

Citation:

Interventional Cardiology 2011;6(2):182–5

HORIZONS and Drug-eluting Stent Usage in Acute Myocardial Infarction

Citation:

Interventional Cardiology 2009;4(1):53-6

Innovative Cardiac Diagnostics - Key to the Total Management of Cardiovascular Disease

Citation:

Asia-Pacific Cardiology 2011;3(1):19–29

ST-segment Elevation Myocardial Infarction in a Patient with Polycythemia Vera Managed with High-dose Tirofiban Pre-treatment, Aspiration Thrombectomy, and Paclitaxel-eluting Stent Implantation

Citation:

US Cardiology 2011;8(1):66–9